Source:-https://www.healthcarepackaging.com Stevanato Group, a global provider of integrated containment and delivery systems to the biopharmaceutical and life sciences industries, has launched an Artificial Intelligence platform, based on Deep Learning (DL) models, designed to leverage the benefits of human-like decision-making in automatic visual inspection equipment. The platform is made to allow pharma companies to overcome the traditional trade-off between detection rate and false rejection rate, ensuring robust and replicable results. False rejects can be significantly reduced and the detection rate improved,